As federal legislators continue to debate the finer points of a broad spending bill, the National Defense Authorization Act , a newly published version of the legislation excludes cannabis banking reform language that had been previously included.
Marijuana Moment first reported the news on Tuesday.
The U.S. House has repeatedly passed the framework of the SAFE Banking Act, which would provide a legitimate legal avenue for financial institutions to work with private cannabis businesses. The addition of the banking reform language in the NDAA was the House’s latest attempt to get this policy approved as law.
The U.S. Senate, meanwhile, had not yet acted on any version of the banking reform bill. And as the NDAA works its way through the legislature, U.S. senators won’t have a chance to chime in on the SAFE Banking Act at this point, either.
“I'm disappointed #SAFEBanking is not included in the NDAA bill text released today,” U.S. Rep. Ed Perlmutter, a sponsor of the banking reform bill, tweeted. “The Senate insists on burying its head in the sand and deny every opportunity to reform our outdated cannabis laws to align state and federal law to improve public safety.”
After years of debate on the matter, the question (and the timing) of banking reform remains elusive in Congress.
see the consequences every day of the lack of banking access, from the rash of
dispensary robberies to the ongoing challenges of minority and small business
owners to secure capital," Steven
Hawkins, CEO of US Cannabis Council, said in a public statement. "The SAFE Banking Act would provide urgently needed
relief to cannabis businesses of all sizes and put wind in the sails of the
broader push to end federal cannabis prohibition."
In a court case involving a recent product recall in Michigan, Michigan Court of Claims Judge Christopher Murray granted Viridis Laboratories a preliminary injunction for a recall of products that one of its labs tested, but denied a preliminary injunction for a recall at another of the company’s labs, according to the Detroit Free Press.
RELATED: Michigan Marijuana Regulatory Agency Issues Recall for Several Cannabis Products
The Dec. 3 decision means that about half the recalled product will be released from recall.
The recall pertaining to products tested at Viridis Laboratories, located in Lansing, was upheld. The recall pertaining to products tested at Viridis North in Bay City was overturned. Both labs share ownership but are separate LLCs, according to the Detroit Free Press.
The Marijuana Regulatory Agency (MRA) issued a bulletin on Dec. 3 stating that the recall on Viridis North products had been enjoined and that the agency “will release the administrative holds on all products” that were recalled after the lab tested them.
Previously, the MRA cited in its original Nov. 17 recall notice that consumers of the recalled products who have lung diseases or weakened immune systems are at the highest risk of developing aspergillosis.
In their lawsuit, the labs contended that the agency had targeted Viridis—which by its own estimation tests between 60 and 70% of Michigan’s cannabis products—to point cannabis businesses to work with other testing labs, according to the Detroit Free-Press.
“While we maintain that the entire recall was completely without merit, we applaud the court for at least reversing the MRA’s faulty decision to recall products tested at Viridis Bay City,” Kevin Blair, an attorney with Honigman LLP, said in an emailed statement also obtained by other media.
MIAMI, Florida, December 6, 2021 - PRESS RELEASE - Ayr Wellness, Inc. (Ayr), a vertically integrated multistate cannabis operator, announced it has received a Temporary Certificate of Occupancy (TCO) to begin operations in its Phoenix, Ariz., cultivation facility.
"Ayr continues to execute on its plan for growth, with this Phoenix cultivation facility being the latest project to come online," said Jonathan Sandelman, Ayr founder, chairman and CEO. "Our talented cultivation team has already received great reviews for the Kynd premium flower being grown in our Chandler, Arizona facility, and we look forward to scaling production with this larger space. The flower produced will supply our three Oasis dispensaries, as well as our growing wholesale business in the state."
The first crop was planted over the weekend, with its first harvest projected for mid-March 2022.
The company anticipates receiving local and regulatory approvals for additional sections of the cultivation facility in the coming weeks.
据《底特律自由报》报道，在涉及密歇根州最近产品召回的一个法庭案件中，密歇根州索赔法院法官克里斯托弗·默里（Christopher Murray）授予Viridis Laboratories一项初步禁令，要求召回其一个实验室测试的产品，但拒绝了该公司另一个实验室的初步召回禁令。
霍尼格曼有限责任公司（Honigman LLP）的律师凯文·布莱尔（Kevin Blair）在一份电子邮件声明中表示：“虽然我们坚持认为整个召回完全没有法律依据，但我们赞扬法院至少推翻了MRA召回在Viridis Bay City测试的产品的错误决定。”其他媒体也获得了这份声明。